doi: 10.1038/ajg.2010.181.
FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change
Affiliations
- PMID: 20818351
- DOI: 10.1038/ajg.2010.181
Item in Clipboard
FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change
Am J Gastroenterol.
2010 Sep.
Abstract
Although fecal immunochemical tests (FITs) have been used for colorectal cancer (CRC) screening in several countries for years, this has not been the case in the United States. The reasons for this are multifactorial, but if the United States hopes to increase screening rates, the evidence is in regarding FIT's benefits and potential. A publication in this issue of the American Journal of Gastroenterology provides "gold standard" evidence of its superiority over the standard guaiac test and opens opportunities for investigators to discover the most effective uses of this test for population screening.
Similar articles
-
Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25. Am J Gastroenterol. 2010. PMID: 20502450
-
New fecal occult blood tests may improve adherence and mortality rates.Cleve Clin J Med. 2011 Aug;78(8):515-20. doi: 10.3949/ccjm.78a.11024. Cleve Clin J Med. 2011. PMID: 21807923 Review.
-
Performance improvements of stool-based screening tests.Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):479-92. doi: 10.1016/j.bpg.2010.03.009. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833351 Review.
-
Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4. Eur J Cancer. 2010. PMID: 20621736 Clinical Trial.
-
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. doi: 10.1093/jnci/djm150. Epub 2007 Sep 25. J Natl Cancer Inst. 2007. PMID: 17895475
Cited by
-
Balancing Adherence and Expense: The Cost-Effectiveness of Two-Sample vs One-Sample Fecal Immunochemical Test.Popul Health Manag. 2019 Feb;22(1):83-89. doi: 10.1089/pop.2018.0008. Epub 2018 Jun 21. Popul Health Manag. 2019. PMID: 29927702 Free PMC article.
-
Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.BMC Cancer. 2018 May 2;18(1):509. doi: 10.1186/s12885-018-4402-x. BMC Cancer. 2018. PMID: 29720130 Free PMC article.
-
Barriers and Facilitators to Colorectal Cancer Screening Among Rural Women in Community Clinics by Heath Literacy.J Womens Health Issues Care. 2017;6(6):1000292. doi: 10.4172/2325-9795.1000292. Epub 2017 Oct 25. J Womens Health Issues Care. 2017. PMID: 29568788 Free PMC article.
-
Fecal immunochemical test for colorectal cancer from a prospective cohort with 513,283 individuals: Providing detailed number needed to scope (NNS) before colonoscopy.Medicine (Baltimore). 2016 Sep;95(36):e4414. doi: 10.1097/MD.0000000000004414. Medicine (Baltimore). 2016. PMID: 27603337 Free PMC article.
-
A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.Clin Colorectal Cancer. 2016 Jun;15(2):186-194.e13. doi: 10.1016/j.clcc.2016.02.004. Epub 2016 Mar 25. Clin Colorectal Cancer. 2016. PMID: 27237338 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
